Continuing Rebound of Mass Spec Business Helps Waters Post 14-Percent Rise in Q1 Revs | GenomeWeb
Strong instrument sales, especially in its newly refreshed mass-spectrometry portfolio, fueled a 14-percent jump in total sales for the first quarter, Waters reported this week.
 
CEO Douglas Berthiaume also hinted that the company may make an acquisition sometime this year.
 
Shipments of the company’s mass specs rose 12 percent year-over-year, helping overall sales climb to $331 million for the three months ended March 31, compared to $290 million a year ago.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.